R&D Results, reality, and recalibration: Unpacking AI hype at SC... SCOPE 2026 was dominated by one big topic: AI. You couldn’t walk five steps without hearing about something that AI was going to fix.
Sales & Marketing People, leadership, and change efforts: A Q&A with Mark Gree... A new Q&A seeks to provide insights on how to build change programmes that actually work – from clinical teams to board level.
Sales & Marketing Sponsored Empowering global and local brand teams with digital resourc... Daniel Kohlstaedt, managing director and founder of PurpleLeaf Strategy, explores how moving resource planning into the cloud can lead to more simplified, streamlined, and optimised brand p
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.